Calamos Advisors
SILK

Calamos Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Calamos Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,838
Closed -$1.26M – 1235
2022
Q4 		$1.26M Buy
+23,838
New +$1.16M 0.01% 838

Other funds holding SILK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Calamos Advisors's SILK Position: Q1 2023 in Review

Calamos Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q1 2023, closing a stake of 23,838 shares — an estimated $1.26M sold.

Calamos Advisors first reported a position in SILK in Q4 2022 and held it in 1 quarter. The position peaked at $1.26M in Q4 2022. 194 funds tracked by Wall St. Rank hold SILK as of Q1 2023.

  • Calamos Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Calamos Advisors sold 23,838 Silk Road Medical, Inc. Common Stock shares in Q1 2023, an estimated $1.26M.
  • Calamos Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Calamos Advisors's Silk Road Medical, Inc. Common Stock position peaked at $1.26M in Q4 2022.
  • 194 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.